Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366

1.

Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.

Kales A, Bixler EO, Vela-Bueno A, Soldatos CR, Niklaus DE, Manfredi RL.

Clin Pharmacol Ther. 1986 Oct;40(4):378-86.

PMID:
3530586
2.

Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.

Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby JA, Kales JD.

Clin Pharmacol Ther. 1986 Mar;39(3):345-52.

PMID:
2868823
3.

Quazepam and flurazepam: long-term use and extended withdrawal.

Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, Kales JD.

Clin Pharmacol Ther. 1982 Dec;32(6):781-8.

PMID:
7140142
4.

Quazepam: hypnotic efficacy and side effects.

Kales A.

Pharmacotherapy. 1990;10(1):1-10; discussion 10-2. Review.

PMID:
1969151
5.

A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.

Mamelak M, Csima A, Price V.

J Clin Pharmacol. 1984 Feb-Mar;24(2-3):65-75.

PMID:
6143767
7.

Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).

Saletu B, Anderer P, Brandstätter N, Frey R, Grünberger J, Klösch G, Mandl M, Wetter T, Zeitlhofer J.

Neuropsychobiology. 1994;29(2):69-90.

PMID:
8170529
8.

Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.

Kales A, Kales JD.

J Clin Psychopharmacol. 1983 Apr;3(2):140-50. Review.

PMID:
6132933
9.

Quazepam versus triazolam in patients with sleep disorders: a double-blind study.

Mauri MC, Gianetti S, Pugnetti L, Altamura AC.

Int J Clin Pharmacol Res. 1993;13(3):173-7.

PMID:
7901174
10.

Rebound insomnia and elimination half-life: assessment of individual subject response.

Bixler EO, Kales JD, Kales A, Jacoby JA, Soldatos CR.

J Clin Pharmacol. 1985 Mar;25(2):115-24. Review.

PMID:
2859304
11.

Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.

Mamelak M, Csima A, Price V.

Clin Neuropharmacol. 1985;8 Suppl 1:S63-73. No abstract available.

PMID:
3837688
12.

A review of the safety profiles of benzodiazepine hypnotics.

Roth T, Roehrs TA.

J Clin Psychiatry. 1991 Sep;52 Suppl:38-41. Review.

PMID:
1680124
13.

Benzodiazepine hypnotics and insomnia.

Kales A.

Hosp Pract (Off Ed). 1990 Sep;25 Suppl 3:7-21; discussion 22-3. Review.

PMID:
1976124
14.

Pharmacology and hypnotic efficacy of triazolam.

Roth T, Roehrs TA, Zorick FJ.

Pharmacotherapy. 1983 May-Jun;3(3):137-48.

PMID:
6136026
15.

Early morning insomnia with rapidly eliminated benzodiazepines.

Kales A, Soldatos CR, Bixler EO, Kales JD.

Science. 1983 Apr 1;220(4592):95-7.

PMID:
6131538
17.

Rebound insomnia: a critical review.

Gillin JC, Spinweber CL, Johnson LC.

J Clin Psychopharmacol. 1989 Jun;9(3):161-72. Review.

PMID:
2567741
18.

Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam.

Bliwise D, Seidel W, Karacan I, Mitler M, Roth T, Zorick F, Dement W.

Sleep. 1983;6(2):156-63.

PMID:
6136085
19.

Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.

Soldatos CR, Dikeos DG, Whitehead A.

Int Clin Psychopharmacol. 1999 Sep;14(5):287-303.

PMID:
10529072
20.

Clinical uses and advantages of low doses of benzodiazepine hypnotics.

Vogel G.

J Clin Psychiatry. 1992 Jun;53 Suppl:19-22.

PMID:
1613015

Supplemental Content

Support Center